Review describes scalable testing workflow for emerging infectious diseases
Frequent Testing Beat Lockdowns at Stopping Viral Spread
This after-action report review synthesizes a scalable workflow for specimen collection, analysis, and reporting during the COVID-19 pandemi…
Frequent testing with same-day results stopped viral spread better than lockdowns, proving rapid monitoring protects communities when new vi…
Systematic review finds intestinal microenvironment abnormalities are more severe in HIV immunological non-responders compared to responders.
HIV Treatment Leaves Some Patients Behind. Here's Why.
This systematic review evaluated intestinal immune and microbial differences between people living with HIV (PLWH) classified as immunologic…
Some HIV patients stay vulnerable to illness even after years of successful treatment because their damaged gut fails to rebuild immunity.
Nevirapine plus lamivudine and zidovudine improved lymphocyte counts and reduced adverse effects versus efavirenz in HIV patients.
New HIV drug combo showed fewer side effects and better immune markers in small trial
This randomized controlled trial enrolled 100 patients with HIV/AIDS in a hospital setting. Participants received either lamivudine plus zid…
A new HIV drug combo boosted immune cells and caused fewer side effects than the standard alternative in a recent trial.
HIV/AIDS continues disproportionate impact on U.S. Black or African American population
HIV and AIDS continue to disproportionately affect Black Americans, awareness day notes
A non-research announcement for National Black HIV/AIDS Awareness Day notes the continuing disproportionate impact of HIV infection and AIDS…
National Black HIV/AIDS Awareness Day highlights that HIV and AIDS continue to disproportionately affect Black or African American people in…